The United States and Japan were the primary reporting countries, and the reporting years were concentrated in the past 5 years with an increasing trend year by year.
← all excerpts
Analysis on the risk of myasthenia gravis related to immune checkpoint inhibitors based on the US FDA Adverse Event Reporting System.
1
—
—